Vertex Pharmaceuticals Inc
NASDAQ: VRTX
$439.37
+$14.38 (+3.4%)
Closing Price on May 12, 2025
VRTX Stock Chart and Intraday Price
VRTX Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 50 NORTHERN AVENUE, BOSTON, MA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 111,785.37M USD |
| Shares Outstanding | 258,308,000 |
VRTX Articles
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor...
Published:
The most notable insider purchases of the past week came from return buyers, including Warren Buffett. Another biotech IPO also tempted insiders to scoop up some shares.
Published:
Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their shares into smaller slices. Walmart (NYSE:WMT) split its stock in February,...
Published:
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of these picks. Whether we’re...
Published:
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery...
Published:
There has been a noticeable shift in the stock market over the last two months. Investors are moving away from former high-flying large- and mega-cap stocks into discounted small-cap names that the...
Published:
The tech stock selloff in July surprised the market but not those investors who were paying attention. As far back as April, Goldman Sachs (NYSE:GS) warned of the coming decline. Its analysts said...
Published:
Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in your portfolio, but also because when you invest in them, you’re...
Published:
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Published:
Friday's top analyst upgrades and downgrades included Builders FirstSource, CVS Health, DHT, Incyte, McDonald's, Newell Brands, PacWest Bancorp, Wingstop and ZoomInfo Technologies.
Published:
Wednesday's top analyst upgrades and downgrades included BP, ConocoPhillips, Equity Residential, Exxon Mobil, Global Payments, Kroger, Microsoft, NRG Energy, RingCentral, Valero Energy, Wayfair,...
Published:
Tuesday's top analyst upgrades and downgrades included AT&T, Baxter International, Centene, Darden Restaurants, Lennar, L3 Harris Technologies, MGM Resorts International, Nvidia and Vertex...
Published:
Thursday's top analyst upgrades and downgrades included Analog Devices, Aptiv, CF Industries, Ford, Mosaic, Park Hotels & Resorts, Patterson-UTI Energy, Pinterest, Plug Power, Salesforce, Snap,...
Published:
Wednesday's top analyst upgrades and downgrades included Allbirds, Amazon.com, American Eagle Outfitters, Canopy Growth, Citizens Financial, Cleveland-Cliffs, Etsy, Deere, LyondellBasell Industries,...
Published:
Monday's top analyst upgrades and downgrades included Bill.com, Block, Cigna, Crocs, CommScope, Dish Network, Foot Locker, Gap, Graphic Packaging, Ingersoll Rand, Moderna, Penn National Gaming,...
Published:
